Literature DB >> 8695162

The efficacy of gold-198 grain mold therapy for mucosal carcinomas of the oral cavity.

M Takeda1, H Shibuya, T Inoue.   

Abstract

Gold-198 grain mold therapy was given to 27 patients with 29 oral cancers and the results were analysed. Single plane mold alone was chosen for treatment when the maximum thickness of the tumor was below 2 mm. For thicker tumors, external irradiation prior to mold therapy was added. The 5-year survival following these principles was 82%. Initial tumor control was obtained in all 27 lesions followed for more than 2 years but recurrence took place in 7 (26%). Of 20 patients whose primary lesion did not recur within 2 years, 6 subsequently required surgery (2 cases) or non-surgical treatment (4 cases) for bone complications. The results obtained by single plane mold therapy are encouraging, particularly with regard to gum cancers showing a minimum bone invasion, and should therefore be advocated for selected patients with oral carcinoma.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8695162     DOI: 10.3109/02841869609109923

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  5 in total

1.  Disease control using low-dose-rate brachytherapy is unaffected by comorbid severity in oral cancer patients.

Authors:  R Yoshimura; H Shibuya; K Hayashi; K Toda; H Watanabe; M Miura
Journal:  Br J Radiol       Date:  2011-01-11       Impact factor: 3.039

Review 2.  Current status and perspectives of brachytherapy for head and neck cancer.

Authors:  Hitoshi Shibuya
Journal:  Int J Clin Oncol       Date:  2009-02-20       Impact factor: 3.402

3.  High-dose-rate brachytherapy using molds for lip and oral cavity tumors.

Authors:  Teruhisa Unetsubo; Hidenobu Matsuzaki; Mitsuhiro Takemoto; Kuniaki Katsui; Marina Hara; Norihisa Katayama; Takahiro Waki; Susumu Kanazawa; Jun-Ichi Asaumi
Journal:  Radiat Oncol       Date:  2015-04-08       Impact factor: 3.481

4.  Dosimetric analysis and clinical outcomes in CT-based mould brachytherapy in early oral cancers in patients unfit for surgery.

Authors:  Ashutosh Mukherji; Sinnatamby Mourougan; Kandasamy Saravannan; Singhavajala Vivekanandam; K Sathyanarayana Reddy
Journal:  J Contemp Brachytherapy       Date:  2015-04-01

5.  Surface mould brachytherapy in oral and oropharyngeal cancers.

Authors:  Leonid B Reshko; Jeremy T Gaskins; Jeffrey M Bumpous; Paul A Tennant; Zafrulla Khan; Keith Sowards; Craig L Silverman; Neal E Dunlap
Journal:  Contemp Oncol (Pozn)       Date:  2021-11-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.